Global Bio-chem Technology Group (00809) submitted its monthly return for the period ended 30 November 2025, confirming no changes to its overall share structure compared to the previous month. The total authorized share capital remains HKD 6,000,000,000, equally divided between ordinary shares and convertible preference shares at a par value of HKD 0.1 each.

As of 30 November 2025, the number of issued ordinary shares stood at 16,832,771,527, of which 44,560,000 were held as treasury shares. The remaining 16,788,211,527 ordinary shares were in issuance. The number of issued preference shares was 17,267,750,569, with an aggregate convertible amount of HKD 1,726,775,056.9. The conversion price is HKD 0.1, and these convertibles carry the potential to be transformed into ordinary shares.

The submission date for the filing was 01 December 2025, adhering to the applicable listing rules and relevant legal requirements.